Menu
Advanced
Structure search
List search
EN
CN
ES
FR
JP
KR
Wish Lists
Cart
Sign in
Sign in
Contact us
Catalog
of Screening Compounds
Screening Libraries
Building Blocks
Al/ML Data sets
new
Advanced
Structure search
List search
Homepage
>
Company
>
Media
>
Company news
Company news
Astellas Receives Positive CHMP Opinion for XTANDI™ (enzalutamide) for Patients with Metastatic Hormone-Sensitive Prostate Cancer
TOKYO, Japan I March 26, 2021 - Astellas Pharma Inc.
Endo pays $658M in a further bet on collagen-based medicines, buying out longtime biopharma partner
A little less than two years after Endo Pharmaceuticals’ deal to purchase Somerset Therapeutics fell through, the Irish drugmaker is returning to the well with a much bigger acquisition.
ChemDiv Created Unique KATO TM Platform for Development of Innovative Drugs Against Coronavirus Infection
San Diego, CA, August 12, 2020 – ChemDiv Inc.
ChemDiv, Inc. Opens the Unique Chemistry E-Commerce Store Offering the World's Largest Small Molecule Inventory at STORE.CHEMDIV.COM
STORE.
Viriom, Inc. announced the initiation of a Phase 2 clinical study to evaluate the efficacy of elsulfavirine in adults with moderate manifestations of COVID-19 (novel coronavirus).
San Diego, CA --(PR NEWSWIRE) --April 8, 2020 -- Viriom, Inc.
Viriom Launches Reproductive Toxicity Studies for Elpida® (Elsulfavirine) Once Weekly Oral Formulation
SAN DIEGO, Dec.
New article "A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling"
Congratulations to Nikolay Savchuk and Matthew Parker, with the release of the article “A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling”, in which they ...
i2020 Accelerator Invests in Developing Novel Highly-Specific Approaches to Treatment of Neurodegenerative Diseases Based on Previously Unrecognized Protein-Protein Interactions
i2020 Accelerator announced today its plans to invest in a cutting-edge research program based out of the University of Turku (UTU), Finland.
Insilico Medicine and ChemDiv form a strategic drug discovery service alliance
SanDiego (CA) - Insilico Medicine and ChemDiv, Inc.
AI gets access to big novel chemistry space for quick and effective drug discovery
San Diego (CA) - InsilicoMedicine, in collaboration with ChemDiv, Inc.
“First Principle” Concept in Designing Small Molecules for Targeting RNA Expansion Repeats
ChemDiv present's new scientific poster "“First Principle” Concept in Designing Small Molecules for Targeting RNA Expansion Repeats"The massive of the genome sequencing data has esta...
ChemDiv Posters At “EFMC-ASMC’19”: Macrocyclic Peptidomimetics And Library of Covalent Inhibitors
During “International Symposium EFMC-ASMC’19” in Athens, September 1-5, 2019 Head of Chemistry Dr.
1
2
3
4
5
6
7
8
0
item
s
in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Preplated libraries
Inhibitors and Approved Drugs
Screening Compounds
Building blocks
Inhibitors and approved drugs
Drug Discovery Services
Al/ML Data sets
Synthetic and Medicinal Chemistry
In silico drug design (CADD)
Discovery biology
ADME, DMPK
Functional ex vivo and in vivo models
Safety and Toxicology
Company
News & Media
Contact us
Trends in discovery compounds
